Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 57

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair

Hanwright, Philip J., Qiu, Chenhu, Rath, Jennifer, Zhou, Yang, von Guionneau, Nicholas, Sarhane, Karim A., Harris, Thomas G.W., Howard, Gregory P., Malapati, Harsha, Lan, Michael J., Reddy, Sashank, Hoke, Ahmet, Mao, Hai-Quan, Tuffaha, Sami H. · 2022 · Biomaterials

Abstract

Functional recovery following peripheral nerve injury is limited by progressive atrophy of denervated muscle and Schwann cells (SCs) that occurs during the long regenerative period prior to end-organ reinnervation. Insulin-like growth factor 1 (IGF-1) is a potent mitogen with well-described trophic and anti-apoptotic effects on neurons, myocytes, and SCs. Achieving sustained, targeted delivery of small protein therapeutics remains a challenge. We hypothesized that a novel nanoparticle (NP) delivery system can provide controlled release of bioactive IGF-1 targeted to denervated muscle and nerve tissue to achieve improved motor recovery through amelioration of denervation-induced muscle atrophy and SC senescence and enhanced axonal regeneration. Biodegradable NPs with encapsulated IGF-1/dextran sulfate polyelectrolyte complexes were formulated using a flash nanoprecipitation method to preserve IGF-1 bioactivity and maximize encapsulation efficiencies. Under optimized conditions, uniform PEG-b-PCL NPs were generated with an encapsulation efficiency of 88.4%, loading level of 14.2%, and a near-zero-order release of bioactive IGF-1 for more than 20 days in vitro. The effects of locally delivered IGF-1 NPs on denervated muscle and SCs were assessed in a rat median nerve transection-without- repair model. The effects of IGF-1 NPs on axonal regeneration, muscle atrophy, reinnervation, and recovery of motor function were assessed in a model in which chronic denervation is induced prior to nerve repair. IGF-1 NP treatment resulted in significantly greater recovery of forepaw grip strength, decreased denervation-induced muscle atrophy, decreased SC senescence, and improved neuromuscular reinnervation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2021.121244

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 51

  1. Taylor, 2008, The incidence of peripheral nerve injury in extremity trauma, Am. J. Phys. Med. Rehabil., 87, 381, 10.1097/PHM.0b013e31815e6370 · DOI · Paper page
  2. Bruyns, 2003, Predictors for return to work in patients with median and ulnar nerve injuries, J. Hand Surg., 28, 28, 10.1053/jhsu.2003.50026 · DOI · Paper page
  3. Carlson, 1996, Studies on the regenerative recovery of long-term denervated muscle in rats, Restor. Neurol. Neurosci., 10, 77
  4. Grinsell, 2014, Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies, BioMed Res. Int., 2014, 698256, 10.1155/2014/698256 · DOI · Paper page
  5. Sulaiman, 2000, Effects of short- and long-term Schwann cell denervation on peripheral nerve regeneration, myelination, and size, Glia, 32, 234, 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3 · DOI · Paper page
  6. Gordon, 2011, The basis for diminished functional recovery after delayed peripheral nerve repair, J. Neurosci., 31, 5325, 10.1523/JNEUROSCI.6156-10.2011 · DOI · Paper page
  7. Feldman, 1997, Insulin-like growth factors regulate neuronal differentiation and survival, Neurobiol. Dis., 4, 201, 10.1006/nbdi.1997.0156 · DOI · Paper page
  8. Kanje, 1989, Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve, Brain Res., 486, 396, 10.1016/0006-8993(89)90531-3 · DOI · Paper page
  9. Apel, 2010, Effect of locally delivered IGF-1 on nerve regeneration during aging: an experimental study in rats, Muscle Nerve, 41, 335, 10.1002/mus.21485 · DOI
  10. Ishii, 1994, Role of insulin-like growth factors in peripheral nerve regeneration, Pharmacol. Ther., 62, 125, 10.1016/0163-7258(94)90007-8 · DOI
  11. Shavlakadze, 2005, Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy, Neuromuscul. Disord., 15, 139, 10.1016/j.nmd.2004.10.013 · DOI
  12. Stitt, 2004, The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors, Mol. Cell., 14, 395, 10.1016/S1097-2765(04)00211-4 · DOI · Paper page
  13. Heszele, 2004, Insulin-like growth factor I: the yin and yang of muscle atrophy, Endocrinology, 145, 4803, 10.1210/en.2004-1037 · DOI
  14. Delaney, 2001, Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells, J. Neuropathol. Exp. Neurol., 60, 147, 10.1093/jnen/60.2.147 · DOI
  15. Schumacher, 1993, Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP, Glia, 8, 232, 10.1002/glia.440080403 · DOI
  16. Yan, 2018, Anti-apoptotic effect of IGF1 on Schwann exposed to hyperglycemia is mediated by neuritin, a novel neurotrophic factor, Mol. Neurobiol., 55, 495, 10.1007/s12035-016-0331-3 · doi:10.1007/s12035-016-0331-3
  17. Cheng, 2000, IGF-I promotes Schwann cell motility and survival via activation of Akt, Mol. Cell. Endocrinol., 170, 211, 10.1016/S0303-7207(00)00324-5 · DOI
  18. Tuffaha, 2016, Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury, Expert Opin. Ther. Targets, 20, 1259, 10.1080/14728222.2016.1188079 · DOI
  19. Ishii, 1993, Regulation of peripheral nerve regeneration by insulin-like growth factors, Ann. N. Y. Acad. Sci., 692, 172, 10.1111/j.1749-6632.1993.tb26215.x · doi:10.1111/j.1749-6632.1993.tb26215.x
  20. Tuffaha, 2016, Growth hormone therapy accelerates axonal regeneration, promotes motor reinnervation, and reduces muscle atrophy following peripheral nerve injury, Plast. Reconstr. Surg., 137, 1771, 10.1097/PRS.0000000000002188 · DOI
  21. Bianchi, 2017, Neurotrophic and neuroregenerative effects of GH/IGF1, Int. J. Mol. Sci., 18, 2441, 10.3390/ijms18112441 · DOI · Paper page
  22. Saceda, 2011, Effect of recombinant human growth hormone on peripheral nerve regeneration: experimental work on the ulnar nerve of the rat, Neurosci. Lett., 504, 146, 10.1016/j.neulet.2011.09.020 · doi:10.1016/j.neulet.2011.09.020
  23. Lopez, 2019, Growth hormone improves nerve regeneration, muscle re-innervation, and functional outcomes after chronic denervation injury, Sci. Rep., 9, 3117, 10.1038/s41598-019-39738-6 · DOI
  24. Sjoberg, 1989, Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve, Brain Res., 485, 102, 10.1016/0006-8993(89)90671-9 · DOI · Paper page
  25. Kanje, 1991, Does insulin-like growth factor I (IGF-1) trigger the cell body reaction in the rat sciatic nerve?, Brain Res., 563, 285, 10.1016/0006-8993(91)91547-E · doi:10.1016/0006-8993(91)91547-e
  26. Emel, 2011, Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model, J. Neurosurg., 114, 522, 10.3171/2010.9.JNS091928 · DOI
  27. Tiangco, 2001, IGF-I and end-to-side nerve repair: a dose-response study, J. Reconstr. Microsurg., 17, 247, 10.1055/s-2001-14516 · doi:10.1055/s-2001-14516
  28. Fansa, 2002, Influence of insulin-like growth factor-I (IGF-I) on nerve autografts and tissue-engineered nerve grafts, Muscle Nerve, 26, 87, 10.1002/mus.10165 · DOI
  29. Tae, 2006, PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor, J. Biomater. Sci. Polym. Ed., 17, 187, 10.1163/156856206774879090 · DOI
  30. Wang, 2018, Enzymatically cross-linked hydrogels based on a linear poly (ethylene glycol) analogue for controlled protein release and 3D cell culture, J. Mater. Chem. B, 6, 6067, 10.1039/C8TB01949E · DOI
  31. Tang, 2018, Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery, Nat. Biotechnol., 36, 707, 10.1038/nbt.4181 · DOI · Paper page
  32. He, 2019, Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes, J. Contr. Release, 301, 119, 10.1016/j.jconrel.2019.03.014 · DOI
  33. Xu, 2017, High strength astringent hydrogels using protein as the building block for physically cross- linked multi-network, ACS Appl. Mater. Interfaces, 10, 7593, 10.1021/acsami.7b04290 · DOI
  34. Majumder, 2019, Nanocarrier-based systems for targeted and site specific therapeutic delivery, Adv. Drug Deliv. Rev., 144, 57, 10.1016/j.addr.2019.07.010 · DOI · Paper page
  35. Park, 2012, Multi-arm histidine copolymer for controlled release of insulin from poly (lactide-co-glycolide) microsphere, Biomaterials, 33, 8848, 10.1016/j.biomaterials.2012.08.042 · DOI
  36. Johnson, 2003, Flash nanoprecipitation of organic actives and block copolymers using a confined impinging jets mixer, Aust. J. Chem., 56, 1021, 10.1071/CH03115 · DOI · Paper page
  37. Markwalter, 2018, Design of a small-scale multi-inlet vortex mixer for scalable nanoparticle production and application to the encapsulation of biologics by inverse flash nanoprecipitation, J. Pharmacol. Sci., 107, 2465, 10.1016/j.xphs.2018.05.003 · DOI
  38. Markwalter, 2020, Polymeric nanocarrier formulations of biologics using inverse flash nanoprecipitation, AAPS J., 22, 1, 10.1208/s12248-019-0405-z · DOI
  39. He, 2018, Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery, Acta Biomater., 81, 195, 10.1016/j.actbio.2018.09.047 · DOI
  40. He, 2019, Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes, J. Contr. Release, 301, 119, 10.1016/j.jconrel.2019.03.014 · DOI
  41. Hunter, 2009, Insulin/IGF‐1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function, J. Thromb. Haemostasis, 7, 2123, 10.1111/j.1538-7836.2009.03637.x · DOI
  42. Hanwright, 2019, Stimulated grip strength measurement: validation of a novel method for functional assessment, Muscle Nerve, 60, 437, 10.1002/mus.26646 · doi:10.1002/mus.26646
  43. Glazner, 1995, Insulin-like growth factor gene expression in rat muscle during reinnervation, Muscle Nerve, 18, 1433, 10.1002/mus.880181214 · DOI
  44. Stewart, 1996, Regulation of rat Schwann cell Po expression and DNA synthesis by insulin-like growth factors in vitro, Eur. J. Neurosci., 8, 553, 10.1111/j.1460-9568.1996.tb01240.x · DOI
  45. Fex, 1996, Insulin and the insulin-like growth factors I and II are mitogenic to cultured rat sciatic nerve segments and stimulate [3H]-thymidine incorporation through their respective receptors, Glia, 18, 68, 10.1002/(SICI)1098-1136(199609)18:1<68::AID-GLIA7>3.0.CO;2-# · DOI
  46. Caroni, 1990, Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors, J. Cell Biol., 110, 1307, 10.1083/jcb.110.4.1307 · DOI · Paper page
  47. Raimondo, 2019, Combined delivery of VEGF and IGF-1 promotes functional innervation in mice and improves muscle transplantation in rabbits, Biomaterials, 216, 119246, 10.1016/j.biomaterials.2019.119246 · DOI
  48. Lehmann, 2012, Human Schwann cells retain essential phenotype characteristics after immortalization, Stem Cell. Dev., 21, 423, 10.1089/scd.2010.0513 · doi:10.1089/scd.2010.0513
  49. Wen, 1985, MyoVision: software for automated high-content analysis of skeletal muscle immunohistochemistry, J. Appl. Physiol., 124, 40, 10.1152/japplphysiol.00762.2017 · DOI · Paper page
  50. Kern, 2017, A novel rodent orthotopic forelimb transplantation model that allows for reliable assessment of functional recovery resulting from nerve regeneration, Am. J. Transplant., 17, 622, 10.1111/ajt.14007 · doi:10.1111/ajt.14007
  51. Sulaiman, 2009, Role of chronic Schwann cell denervation in poor functional recovery after nerve injuries and experimental strategies to combat it, Neurosurgery, 65, A105, 10.1227/01.NEU.0000358537.30354.63 · DOI

Cited by

See all 57

Metadata

Authors
Hanwright, P. J., Qiu, C., Rath, J., Zhou, Y., von Guionneau, N., Sarhane, K. A., Harris, T. G. W., Howard, G. P., Malapati, H., Lan, M. J., Reddy, S., Hoke, A., Mao, H.-Q., & Tuffaha, S. H.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2022-01
Volume
280
Pages
121244
ISSN
0142-9612
Cited by
57
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair. https://app.cochat.ai/papers/10.1016/j.biomaterials.2021.121244
The paper
Hanwright, P. J., Qiu, C., Rath, J., Zhou, Y., von Guionneau, N., Sarhane, K. A., Harris, T. G. W., Howard, G. P., Malapati, H., Lan, M. J., Reddy, S., Hoke, A., Mao, H.-Q., & Tuffaha, S. H. (2022). Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair. Biomaterials. https://doi.org/10.1016/j.biomaterials.2021.121244

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.